Noah Lechtzin

7PUBLICATIONS
41CO-AUTHORS
MechanobiologyArts therapyPredictive and prognostic markersCarbon capture engineering (excl. sequestration)Medical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 31, 2023
COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success.

Jeremy M Shefner, Ammar Al-Chalabi, Jinsy A Andrews

|Mar 17, 2023
Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS.

Paulos Gebrehiwet, Lisa Meng, Stacy A Rudnicki

|Dec 12, 2022
MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial.

Paulos Gebrehiwet, Lisa Meng, Stacy A Rudnicki

|Jan 01, 2021
The PROSPECT Is Bright for CFTR Modulators.

Kristina Montemayor, Noah Lechtzin

|Sep 28, 2018
Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections.

Christopher H Goss, Yukihiro Kaneko, Lisa Khuu

|Apr 27, 2018
Reply to Martelli et al.: eHealth in Cystic Fibrosis: Promising, but Proof of Concept Is Still Needed.

Noah Lechtzin, Nicole Mayer-Hamblett, Umer Khan

Pageof 2

Frequent Collaborators

3 joint publications

Adriano Chiò

3 joint publications

Carlayne E Jackson

3 joint publications

Jinsy A Andrews

3 joint publications

Jeremy M Shefner